Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment-Related Adverse Events and Outcome in a Clinical Trial of Fluoxetine for Major Depressive Disorder

Treatment-Related Adverse Events and Outcome in a Clinical Trial of Fluoxetine for Major... Treatment-related adverse events (TRAEs), particularly those that occur early on, may increase the likelihood for premature discontinuation of antidepressants. The purpose of this study was to examine the relationship between TRAEs and outcome in depressed outpatients enrolled in an 8-week, 20 mg, open trial of fluoxetine. A total of 384 patients (54.7% women, mean age 39.9 ± 10.5 years) were enrolled in the trial. Study visits occurred at baseline and every other week. Somatic complaints were assessed during each study visit. Somatic complaints that, in the opinion of the evaluating physician, were probably related or related to treatment with fluoxetine were entered in the analysis as TRAEs. We then tested whether 1) developing at least one TRAE, 2) developing at least one moderate or severe TRAE, 3) the number of TRAEs reported during the entire trial, or 4) the number of TRAEs reported during each 2-week interval predicted whether patients would respond to fluoxetine, or prematurely discontinue treatment. None of the above scores predicted whether patients responded to or prematurely discontinued the trial.These findings failed to reveal any relationship between side effects and treatment outcome for patients with MDD enrolled in an 8-week, 20 mg, fixed dose, open trial of fluoxetine. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Clinical Psychiatry Springer Journals

Treatment-Related Adverse Events and Outcome in a Clinical Trial of Fluoxetine for Major Depressive Disorder

Download PDF
6 pages

Loading next page...
 
/lp/springer-journals/treatment-related-adverse-events-and-outcome-in-a-clinical-trial-of-jFOZTQI0Wl
Publisher
Springer Journals
Copyright
Copyright © 2003 by American Academy of Clinical Psychiatrists
Subject
Medicine & Public Health; Neurology; Psychiatry; Psychopharmacology
ISSN
1040-1237
eISSN
1573-3238
DOI
10.1023/B:ACLI.0000008172.20590.22
Publisher site
See Article on Publisher Site

Abstract

Treatment-related adverse events (TRAEs), particularly those that occur early on, may increase the likelihood for premature discontinuation of antidepressants. The purpose of this study was to examine the relationship between TRAEs and outcome in depressed outpatients enrolled in an 8-week, 20 mg, open trial of fluoxetine. A total of 384 patients (54.7% women, mean age 39.9 ± 10.5 years) were enrolled in the trial. Study visits occurred at baseline and every other week. Somatic complaints were assessed during each study visit. Somatic complaints that, in the opinion of the evaluating physician, were probably related or related to treatment with fluoxetine were entered in the analysis as TRAEs. We then tested whether 1) developing at least one TRAE, 2) developing at least one moderate or severe TRAE, 3) the number of TRAEs reported during the entire trial, or 4) the number of TRAEs reported during each 2-week interval predicted whether patients would respond to fluoxetine, or prematurely discontinue treatment. None of the above scores predicted whether patients responded to or prematurely discontinued the trial.These findings failed to reveal any relationship between side effects and treatment outcome for patients with MDD enrolled in an 8-week, 20 mg, fixed dose, open trial of fluoxetine.

Journal

Annals of Clinical Psychiatry – Springer Journals

Published: Oct 11, 2004

References

  • Side effects and time course of response in a placebo-controlled trial of fluoxetine for the treatment of geriatric depression
    Ackerman, DL; Greenland, S; Bystritsky, A; Small, G
  • Antidepressant drug use: Differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine
    Dittman, RW; Linden, M; Osterheide, M; Schaa, B; Ohnmacht, U; Weber, HJ
  • Early termination of antidepressant drug treatment
    Linden, M; Gothe, H; Dittman, RW; Schaaf, B
  • A meta-analysis of fluoxetine outcome in the treatment of depression
    Greenberg, RP; Bornstein, RF; Zborowski, MJ; Fisher, S; Greenberg, MD
  • Structured Clinical Interview for DSM-III-R-Patient edition (SCID-P)
    Spitzer, RL; Williams, JB; Gibbon, M; First, MB
  • A rating scale for depression
    Hamilton, M
  • Multiple comparisons among means
    Dunn, OJ
  • Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: A meta-analysis of the 20 mg dose
    Beasley, CM; Nilsson, ME; Gonzales, JS
  • Fluoxetine: Relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression
    Beasley, CM; Bosomworth, JC; Wernicke, JF